ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Reduced adiponectin plasma levels have been also observed in various liver diseases such as non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), or hepatocellular carcinoma (HCC) (Gamberi et al. 2018; Shabalala et al. 2020).